Your browser doesn't support javascript.
loading
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
Amgad, Mohamed; Stovgaard, Elisabeth Specht; Balslev, Eva; Thagaard, Jeppe; Chen, Weijie; Dudgeon, Sarah; Sharma, Ashish; Kerner, Jennifer K; Denkert, Carsten; Yuan, Yinyin; AbdulJabbar, Khalid; Wienert, Stephan; Savas, Peter; Voorwerk, Leonie; Beck, Andrew H; Madabhushi, Anant; Hartman, Johan; Sebastian, Manu M; Horlings, Hugo M; Hudecek, Jan; Ciompi, Francesco; Moore, David A; Singh, Rajendra; Roblin, Elvire; Balancin, Marcelo Luiz; Mathieu, Marie-Christine; Lennerz, Jochen K; Kirtani, Pawan; Chen, I-Chun; Braybrooke, Jeremy P; Pruneri, Giancarlo; Demaria, Sandra; Adams, Sylvia; Schnitt, Stuart J; Lakhani, Sunil R; Rojo, Federico; Comerma, Laura; Badve, Sunil S; Khojasteh, Mehrnoush; Symmans, W Fraser; Sotiriou, Christos; Gonzalez-Ericsson, Paula; Pogue-Geile, Katherine L; Kim, Rim S; Rimm, David L; Viale, Giuseppe; Hewitt, Stephen M; Bartlett, John M S; Penault-Llorca, Frédérique; Goel, Shom.
Afiliación
  • Amgad M; 1Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA USA.
  • Stovgaard ES; 2Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark.
  • Balslev E; 2Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark.
  • Thagaard J; 3DTU Compute, Department of Applied Mathematics, Technical University of Denmark, Lyngby, Denmark.
  • Chen W; Visiopharm A/S, Hørsholm, Denmark.
  • Dudgeon S; FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, MD USA.
  • Sharma A; FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, MD USA.
  • Kerner JK; 1Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA USA.
  • Denkert C; 6PathAI, Cambridge, MA USA.
  • Yuan Y; 7Institut für Pathologie, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • AbdulJabbar K; 8Institute of Pathology, Philipps-University Marburg, Marburg, Germany.
  • Wienert S; German Cancer Consortium (DKTK), Partner Site Charité, Berlin, Germany.
  • Savas P; 10Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Voorwerk L; 11Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Beck AH; 10Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Madabhushi A; 11Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Hartman J; 7Institut für Pathologie, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • Sebastian MM; 12Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia.
  • Horlings HM; 13Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Hudecek J; 14Department of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Ciompi F; 6PathAI, Cambridge, MA USA.
  • Moore DA; 15Case Western Reserve University, Department of Biomedical Engineering, Cleveland, OH USA.
  • Singh R; 16Louis Stokes Cleveland Veterans Administration Medical Center, Cleveland, OH USA.
  • Roblin E; 17Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Solna, Sweden.
  • Balancin ML; 18Departments of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
  • Mathieu MC; 19Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Lennerz JK; 20Department of Research IT, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kirtani P; 21Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Chen IC; 22Department of Pathology, UCL Cancer Institute, London, UK.
  • Braybrooke JP; 23Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai, New York, NY USA.
  • Pruneri G; 24Université Paris-Saclay, Univ. Paris-Sud, Villejuif, France.
  • Demaria S; 25Department of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
  • Adams S; 26Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Schnitt SJ; 27Department of Pathology, Massachusetts General Hospital, Boston, MA USA.
  • Lakhani SR; Department of Histopathology, Manipal Hospitals Dwarka, New Delhi, India.
  • Rojo F; 29Department of Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Comerma L; 30Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Badve SS; 31Department of Medical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Khojasteh M; 32Pathology Department, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, School of Medicine, Milan, Italy.
  • Symmans WF; 33Weill Cornell Medical College, New York, NY USA.
  • Sotiriou C; 34Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY USA.
  • Gonzalez-Ericsson P; 35Department of Pathology, Brigham and Women's Hospital, Boston, MA USA.
  • Pogue-Geile KL; 36The University of Queensland Centre for Clinical Research and Pathology Queensland, Brisbane, Australia.
  • Kim RS; 37Pathology Department, CIBERONC-Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.
  • Rimm DL; 38GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain.
  • Viale G; 37Pathology Department, CIBERONC-Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.
  • Hewitt SM; 38GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain.
  • Bartlett JMS; 39Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN USA.
  • Penault-Llorca F; Roche Tissue Diagnostics, Digital Pathology, Santa Clara, CA USA.
  • Goel S; 41Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
NPJ Breast Cancer ; 6: 16, 2020.
Article en En | MEDLINE | ID: mdl-32411818